• Most Popular
  • Most Shared

India Ranbaxy launches generic amlodipine in Japan

Tue Apr 8, 2008 4:10am EDT

Stocks

   

MUMBAI, April 8 (Reuters) - Indian drug maker Ranbaxy Laboratories Ltd (RANB.BO) said on Tuesday it had received clearance from Japan's ministry of health and labour welfare for generic hypertension drug amlodipine tablets.

Amlodipine has a market of about $2 billion in Japan, and represents the biggest generic opportunity in that market, Ranbaxy said in a statement.

Ranbaxy markets four products in Japan currently and "has a strong portfolio in the pipeline", which will be introduced in 2008 and 2009, it said.

Ranbaxy has an equal joint venture with Nihon Pharmaceutical Industry Ltd for generics.

Shares in Ranbaxy were down more than 2 percent at 473.90 rupees at 0803 GMT in a weak Mumbai market. (Reporting by Rina Chandran; Editing by Ranjit Gangadharan)



More from Reuters

Photo

Obama blames "systemic failures" in U.S. security

KANEOHE, Hawaii (Reuters) - President Barack Obama on Tuesday blamed a combination of "human and systemic failures" for allowing the botched Christmas Day attack aboard a Detroit-bound U.S. airliner, in his first big test on homeland security. | Video

» More Top News
Leaves gather in front of an empty and boarded-up house in Youngstown, Ohio November 21, 2009. REUTERS/Brian Snyder

Castles built on sand

Rust-belt American cities like Youngstown, Ohio were battered by the downturn. Now they're ready to move on, but it won’t be easy. The first in a three-part report.  Full Article 

Route to Recovery
REUTERS/James Saft
JAMES SAFT:

Welcome to the "Teenies"

Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too.  Commentary 

COMMENTARY